Patents by Inventor Marcus Ruscetti

Marcus Ruscetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108628
    Abstract: The present technology provides methods for treating pancreatic cancer using a MEK inhibitor and a CDK4/6 inhibitor. Also disclosed herein are methods for increasing patient responsiveness to chemotherapeutic and/or immunotherapeutic regimes for pancreatic cancer. Kits for use in practicing the methods are also provided.
    Type: Application
    Filed: April 24, 2023
    Publication date: April 4, 2024
    Inventors: Marcus Ruscetti, John P. Morris, IV, Scott Lowe
  • Patent number: 11633401
    Abstract: The present technology provides methods for treating pancreatic cancer using a MEK inhibitor and a CDK4/6 inhibitor. Also disclosed herein are methods for increasing patient responsiveness to chemotherapeutic and/or immunotherapeutic regimes for pancreatic cancer. Kits for use in practicing the methods are also provided.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: April 25, 2023
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Marcus Ruscetti, John P. Morris, IV, Scott Lowe
  • Publication number: 20210205319
    Abstract: The present technology provides methods for treating pancreatic cancer using a MEK inhibitor and a CDK4/6 inhibitor. Also disclosed herein are methods for increasing patient responsiveness to chemotherapeutic and/or immunotherapeutic regimes for pancreatic cancer. Kits for use in practicing the methods are also provided.
    Type: Application
    Filed: July 3, 2019
    Publication date: July 8, 2021
    Inventors: Marcus Ruscetti, John P. Morris, IV, Scott Lowe